Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Minden

Showing results (191-200 of 308) with videos related to

Pageof 31
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignanciesAaron D Schimmer, Susan O'Brien, Hagop Kantarjian, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 31, 2015
Mitochondrial DNA damage by bleomycin induces AML cell deathManTek Yeung, Rose Hurren, Carine Nemr, et al.
Blood|March 15, 2021
Very long chain fatty acid metabolism is required in acute myeloid leukemiaMatthew Tcheng, Alessia Roma, Nawaz Ahmed, et al.
Blood|July 22, 2021
Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS productionJong Bok Lee, Dilshad H Khan, Rose Hurren, et al.
Investigational New Drugs|July 14, 2016
A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemiaKaren W L Yee, Hsiao-Wei T Chen, David W Hedley, et al.
NAR Genomics and Bioinformatics|February 14, 2022
An improved molecular inversion probe based targeted sequencing approach for low variant allele frequencyTamir Biezuner, Yardena Brilon, Asaf Ben Arye, et al.
Current Oncology (Toronto, Ont.)|March 11, 2021
Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL RegimenRuiqi Chen, Xing Liu, Arjun D Law, et al.
Blood|March 12, 2017
Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AMLSanduni U Liyanage, Rose Hurren, Veronique Voisin, et al.
Oncotarget|February 11, 2017
SMYD2 lysine methyltransferase regulates leukemia cell growth and regeneration after genotoxic stressAdi Zipin-Roitman, Nasma Aqaqe, Muhammad Yassin, et al.
Molecular Cancer Therapeutics|January 8, 2010
Selective inhibition of histone deacetylases sensitizes malignant cells to death receptor ligandsTabitha E Wood, Shadi Dalili, Craig D Simpson, et al.
Pageof 31

Showing results (191-200 of 308) with videos related to

Sort By:
Pageof 31
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignanciesAaron D Schimmer, Susan O'Brien, Hagop Kantarjian, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 31, 2015
Mitochondrial DNA damage by bleomycin induces AML cell deathManTek Yeung, Rose Hurren, Carine Nemr, et al.
Blood|March 15, 2021
Very long chain fatty acid metabolism is required in acute myeloid leukemiaMatthew Tcheng, Alessia Roma, Nawaz Ahmed, et al.
Blood|July 22, 2021
Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS productionJong Bok Lee, Dilshad H Khan, Rose Hurren, et al.
Investigational New Drugs|July 14, 2016
A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemiaKaren W L Yee, Hsiao-Wei T Chen, David W Hedley, et al.
NAR Genomics and Bioinformatics|February 14, 2022
An improved molecular inversion probe based targeted sequencing approach for low variant allele frequencyTamir Biezuner, Yardena Brilon, Asaf Ben Arye, et al.
Current Oncology (Toronto, Ont.)|March 11, 2021
Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL RegimenRuiqi Chen, Xing Liu, Arjun D Law, et al.
Blood|March 12, 2017
Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AMLSanduni U Liyanage, Rose Hurren, Veronique Voisin, et al.
Oncotarget|February 11, 2017
SMYD2 lysine methyltransferase regulates leukemia cell growth and regeneration after genotoxic stressAdi Zipin-Roitman, Nasma Aqaqe, Muhammad Yassin, et al.
Molecular Cancer Therapeutics|January 8, 2010
Selective inhibition of histone deacetylases sensitizes malignant cells to death receptor ligandsTabitha E Wood, Shadi Dalili, Craig D Simpson, et al.
Pageof 31